Patients hospitalized with community-acquired pneumonia: A comparative study of outcomes by medical specialty area;Pacientes ingresados por neumonía adquirida en la comunidad: Estudio comparativo en función de la especialidad del servicio médico responsable

Archivos de Bronconeumologia

Volumn 41, Issue 6, 2005, Pages 300-306

  Capelastegui, A ^a   Espana P P ^a   Quintana, J M ^a   Gorordo, I ^a   Martinez Urquiri A ^a   Idoiaga, I ^a   Bilbao, A ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Community acquired pneumonia; Results; Treatment; Variability

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MORTALITY; PATIENT CARE; PHYSICIAN; PNEUMONIA; TREATMENT OUTCOME;

EID: 22544457634     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13075996     Document Type: Article

References (31)

1. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-50.
2. España PP, Capelastegui A, Quintana JM, et al. A prediction rule to identify allocation of inpatient care in community-acquires pneumonia. Eur Respir J. 2003;21:695-701.
3. Ewig S, Kleinfeld T, Bauer T, Seifert K, Schafer H, Goke N. Comparative validation of prognostic rules for community-acquired pneumonia in a elderly population. Eur Respir J. 1998;14:370-5.
4. Neill AM, Martin IR, Weir R, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax. 1996;51:1010-6.
5. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997;278:2080-4.
6. Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ. Associations between inicial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med. 1999;159:2562-72.
7. Stahl JE, Barza M, Desfardin J, Martin R, Eckman MH. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med. 1999;159:2576-80.
8. Fine MJ, Singer DN, Phelps AL, Hanusa BH, Kapoor WN. Differences in the length of stay in patients with community-acquired pneumonia: a prospective four-hospital study. Med Care. 1993;31:371-80.
9. Feagan BG, Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. Can Med Assoc J. 2000;162:1415-20.
10. McCormick D, Fine MJ, Coley CM, et al. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes? Am J Med. 1999;107:5-12.
11. Jin Y, Marrie TJ, Carriere KC, et al. Variation in management of community-acquired pneumonia requiring admission to Alberta, Canada hospitals. Epidemiol Infect. 2001;130:41-51.
12. Wennberg JE, Freeman JL, Gulp WJ. Are hospital services retioned in New Haven or over-utilized in Boston? Lancet. 1987;1:1185-9.
13. Wennberg JE, McPherson K, Caper P. Will payment based on diagnosis-related groups control hospital costs? N Engl J Med. 1984;311:295-300.
14. Ortqvist A. Antibiotic treatment of community-acquired pneumonia in clinical practice: a European survey. J Antimicrob Chemother. 1995;35:205-12.
15. Huchon GJ, Gialdroni-Grassi G, Leophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J. 1996;9:1590-5.
16. Gilbert K, Gleason PP, Singer DE, et al. Variations in antimicrobial use and cost in more than 2000 patients with community-acquired pneumonia. Am J Med. 1998;104:17-27.
17. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA. 1996;275:134-41.
18. Marrie TJ, Carriere KC, Jin Y, Johnson DH. Mortality during hospitalisation for pneumonia in Alberta, Canada, is associated with physician volume. Eur Respir J. 2003;22:148-55.
19. Jong P, Gong Y, Liu PP, Austin PC, Lee DS, Tu JV. Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation. 2003;108:184-91.
20. Harrold LR, Field TS, Gurwitz JH. Knowledge, patterns of care, and outcomes of care for general internists and specialists. J Gen Intern Med. 1999;14:499-511.
21. Pardo A, Durández R, Hernández M, et al. Impact of specialty on the cost of nonvariceal upper GI bleeding care. Am J Gastroenterol. 2002;97:1535-42.
22. Ewig S, Ruiz M, Mensa J, et al. Severe community-acquired pneunonia: assessment of severity criteria. Am J Respir Crit Care Med. 1998;158:1102-8.
23. Dorca J, Bello S, Blanquer J, et al. Diagnóstico y tratamiento de la neumonía adquirida en la comunidad. SEPAR. Sociedad Española de Neumología y Cirugía Toracica. Arch Bronconeumol. 1997;33:240-6.
24. Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med. 1997;157:1453-9.
25. Fernández Álvarez R, Gullon Blanco JA, Rubinos Cuadrado G, et al. Neumonía adquirida en la comunidad: influencia de la duración de la antibioterapia intravenosa en la estancia hospitalaria y relación coste/efectividad. Arch Bronconeumol. 2001;37:366-70.
26. Rhew DC, Tu GS, Ofman J, Henning JM, Richards MS, Weingarten SC. Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis. Arch Intern Med. 2001;161:722-7.
27. Rhew DC, Goetz MB, Shekelle PG. Evaluating quality indicators for patients with community-acquired pneumonia. J Qual Improv. 2001;27:575-90.
28. Halm EA, Fine MJ, Kapoor WN, Singer DE, Marrie TJ, Siu AL. Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia. Arch Intern Med. 2002;162:1278-84.
29. Lim WS, Van der Eerden MM, Laing R, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377-82.
30. Angus DC, Marrie TJ, Obrosky S, et al. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society diagnostic criteria. Am J Respir Crit Care Med. 2002;166:717-23.
31. Eron LJ, Passos S. Early discharge of infected patients through appropriate antibiotic use. Arch Intern Med. 2001;161:61-5.